These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16385890)

  • 1. [Reactions to the New York "supervirus". A challenge in primary resistance].
    Paukstadt W
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():86. PubMed ID: 16385890
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV/AIDS. Experts question danger of 'AIDS superbug'.
    Cohen J
    Science; 2005 Feb; 307(5713):1185. PubMed ID: 15731415
    [No Abstract]   [Full Text] [Related]  

  • 3. The more things change..
    Zuniga JM
    IAPAC Mon; 2005 Mar; 11(3):60-1. PubMed ID: 16110533
    [No Abstract]   [Full Text] [Related]  

  • 4. [Resistance screening].
    Sierra S; Lengauer T; Kaiser R
    MMW Fortschr Med; 2009 Apr; 151(18):72, 74-5. PubMed ID: 19769083
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV-1 tropism, disease progression, and clinical management.
    Burger H; Hoover D
    J Infect Dis; 2008 Oct; 198(8):1095-7. PubMed ID: 18783314
    [No Abstract]   [Full Text] [Related]  

  • 6. Investigation of a new diagnosis of multidrug-resistant, dual-tropic HIV-1 infection--New York City, 2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Jul; 55(29):793-6. PubMed ID: 16874293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The V118I mutation as a marker of advanced HIV infection and disease progression.
    Zaccarelli M; Tozzi V; Lorenzini P; Forbici F; Narciso P; Ceccherini-Silberstein F; Trotta MP; Bertoli A; Liuzzi G; Marconi P; Mosti S; Perno CF; Antinori A
    Antivir Ther; 2007; 12(2):163-8. PubMed ID: 17503658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Integrase inhibition].
    Bogner JR
    MMW Fortschr Med; 2009 Apr; 151(18):68-71. PubMed ID: 19769082
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of advanced stages. "Mega-HAART" or "drug holiday"?].
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():86-7. PubMed ID: 10863323
    [No Abstract]   [Full Text] [Related]  

  • 10. The next big challenge: managing HIV infection in an age of higher resistance.
    AIDS Alert; 2001 Dec; 16(12):153, 155-7. PubMed ID: 11768873
    [No Abstract]   [Full Text] [Related]  

  • 11. The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient.
    Blick G; Kagan RM; Coakley E; Petropoulos C; Maroldo L; Greiger-Zanlungo P; Gretz S; Garton T
    J Infect Dis; 2007 May; 195(9):1250-9. PubMed ID: 17396993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resistance to anti-retroviral therapy in Chilean patients with HIV-1 from 2002 to 2005].
    Afani S A; Orellana R L; Duarte J P; Acevedo M W; Morales B O; Wolff R M; Vásquez P; Beltrán C
    Rev Med Chil; 2007 Oct; 135(10):1237-44. PubMed ID: 18180829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV biological phenotype: prognosis marker for transmission, disease progression and therapy.
    Fenyö EM
    J Biol Regul Homeost Agents; 1995; 9(3):88-90. PubMed ID: 8782013
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
    Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
    Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible HIV "super-strain" in New York City; new human T-lymphotropic viruses identified in Africa.
    Laurence J
    AIDS Read; 2005 Apr; 15(4):155-6. PubMed ID: 15844234
    [No Abstract]   [Full Text] [Related]  

  • 17. Aggressive HIV-1?
    Berkhout B; de Ronde A; van der Hoek L
    Retrovirology; 2005 Feb; 2():13. PubMed ID: 15737238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage therapy.
    Gazzard B
    J HIV Ther; 2005 Mar; 10(1):3-5. PubMed ID: 15951727
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
    Sungkanuparph S; Apiwattanakul N; Thitithanyanont A; Chantratita W; Sirinavin S
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):83-8. PubMed ID: 19323038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for use of antiretroviral therapy for HIV infected individuals in India (ART guidelines 2008).
    Pujari S; Patel A; Joshi SR; Gangakhedkar R; Kumarasamy N; Gupta SB;
    J Assoc Physicians India; 2008 May; 56():339-48, 353-71. PubMed ID: 18700643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.